$0.50 EPS Expected for Core Laboratories N.V. (CLB); Inphi (IPHI) Has 0.86 Sentiment

July 17, 2017 - By Kurt Siggers

Inphi Corporation is a provider of analog and mixed signal semiconductor solutions for the communications and datacenter markets. The company has market cap of $1.61 billion. The Company’s solutions provide an interface between analog signals and digital information in systems, such as telecommunications transport systems, enterprise networking equipment and datacenters. It has a 117.18 P/E ratio. It is engaged in the design, development and sale of analog connectivity components that operate to maintain, amplify and manage signal integrity at high speeds in a range of applications.

Analysts expect Core Laboratories N.V. (NYSE:CLB) to report $0.50 EPS on July, 24 after the close.They anticipate $0.15 EPS change or 42.86% from last quarter’s $0.35 EPS. CLB’s profit would be $22.62 million giving it 53.17 P/E if the $0.50 EPS is correct. After having $0.42 EPS previously, Core Laboratories N.V.’s analysts see 19.05% EPS growth. The stock increased 2.44% or $2.53 on July 14, reaching $106.34. About shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 5.82% since July 17, 2016 and is downtrending. It has underperformed by 22.52% the S&P500.

The stock decreased 0.26% or $0.1 on July 14, reaching $38.38. About shares traded. Inphi Corporation (IPHI) has risen 38.34% since July 17, 2016 and is uptrending. It has outperformed by 21.64% the S&P500.

Oberweis Asset Management Inc holds 3.72% of its portfolio in Inphi Corporation for 279,355 shares. S Squared Technology Llc owns 68,734 shares or 3.33% of their US portfolio. Moreover, Herald Investment Management Ltd has 3.12% invested in the company for 162,000 shares. The New York-based G2 Investment Partners Management Llc has invested 2.39% in the stock. Eventide Asset Management Llc, a Massachusetts-based fund reported 799,100 shares.

Ratings analysis reveals 60% of Inphi’s analysts are positive. Out of 5 Wall Street analysts rating Inphi, 3 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $39.0 while the high is $55.0. The stock’s average target of $48 is 25.07% above today’s ($38.38) share price. IPHI was included in 5 notes of analysts from August 30, 2016. The company was initiated on Tuesday, August 30 by JP Morgan. The rating was initiated by Cowen & Co on Friday, October 14 with “Market Perform”. The firm has “Strong Buy” rating given on Wednesday, November 2 by Needham. Northland Capital downgraded the stock to “Market Perform” rating in Wednesday, September 7 report. The company was maintained on Thursday, October 13 by Stifel Nicolaus.

Since January 1, 0001, it had 0 insider buys, and 9 insider sales for $4.52 million activity.

Analysts await Inphi Corporation (NYSE:IPHI) to report earnings on August, 14. They expect $0.06 EPS, down 62.50% or $0.10 from last year’s $0.16 per share. IPHI’s profit will be $2.52M for 159.92 P/E if the $0.06 EPS becomes a reality. After $0.23 actual EPS reported by Inphi Corporation for the previous quarter, Wall Street now forecasts -73.91% negative EPS growth.

Since January 30, 2017, it had 2 insider buys, and 0 selling transactions for $35,617 activity. 106 Core Laboratories N.V. (NYSE:CLB) shares with value of $12,577 were bought by Straughen Michael. Carnes Martha Z. had bought 200 shares worth $23,040 on Monday, January 30.

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.28, from 1.13 in 2016Q3. It dropped, as 47 investors sold Core Laboratories N.V. shares while 119 reduced holdings. 43 funds opened positions while 98 raised stakes. 44.52 million shares or 3.01% more from 43.21 million shares in 2016Q3 were reported. Cue Fincl Group invested 0.21% in Core Laboratories N.V. (NYSE:CLB). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.02% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Peoples Financial Services holds 0% in Core Laboratories N.V. (NYSE:CLB) or 42 shares. Academy Cap Mngmt Tx owns 69,091 shares for 2.26% of their portfolio. Stephens Incorporated Ar reported 0.01% stake. California Pub Employees Retirement Sys has 0.02% invested in Core Laboratories N.V. (NYSE:CLB) for 89,600 shares. Ubs Asset Mngmt Americas holds 114,731 shares. Bokf Na has 0.02% invested in Core Laboratories N.V. (NYSE:CLB). Blackrock Advsr Limited Liability has 0.01% invested in Core Laboratories N.V. (NYSE:CLB) for 43,544 shares. 1,200 are owned by Joel Isaacson And Limited Liability Corporation. Bnp Paribas Inv Prns Sa invested 0.02% in Core Laboratories N.V. (NYSE:CLB). State Farm Mutual Automobile Insur Company stated it has 0.09% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Marble Harbor Inv Counsel Ltd Liability Co holds 6,701 shares. Bradley Foster & Sargent Incorporated Ct accumulated 9,140 shares. Edge Asset Inc owns 10,000 shares or 0.01% of their US portfolio.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the gas and oil industry. The company has market cap of $4.81 billion. The Firm operates through three divisions: Reservoir Description, Production Enhancement and Reservoir Management. It has a 70.59 P/E ratio. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Among 20 analysts covering Core Laboratories (NYSE:CLB), 9 have Buy rating, 0 Sell and 11 Hold. Therefore 45% are positive. Core Laboratories had 34 analyst reports since August 24, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Citigroup on Monday, May 16. The rating was initiated by JP Morgan with “Overweight” on Friday, June 10. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Neutral” rating by Citigroup on Friday, March 18. The company was maintained on Friday, January 29 by Howard Weil. The rating was maintained by Cowen & Co on Monday, October 26 with “Market Perform”. Morgan Stanley maintained the stock with “Overweight” rating in Tuesday, April 19 report. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Hold” rating by ABN Amro on Monday, April 24. Sterne Agee CRT maintained Core Laboratories N.V. (NYSE:CLB) on Wednesday, September 30 with “Neutral” rating. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Equal-Weight” rating by Stephens on Tuesday, April 5. The stock has “Hold” rating by Scotia Capital on Thursday, March 23.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: